MTNB — Matinas BioPharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Matinas BioPharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58.7	49.6	28.8	13.8	7.28
Prepaid Expenses
Total Other Current Assets
Total Current Assets	61.6	51	34.5	15.5	8.03
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.86	5.78	5.73	5.01	2.16
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	71	61.3	44.8	25.1	12.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.57	4.35	4.29	2.62	2.67
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	7.24	8.83	8.18	5.86	5.05
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	63.7	52.5	36.6	19.2	7.59
Total Liabilities & Shareholders' Equity	71	61.3	44.8	25.1	12.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding